Business Context and Reporting Period
This Form 8-K is a Current Report filed by Viewbix Inc. (not Quantum X Labs Inc., which is the target of the proposed transaction) on November 5, 2025. The filing discloses the entry into a material definitive agreement regarding a strategic acquisition and a concurrent private placement offering.
Key Financial Metrics and Transaction Terms
- Acquisition Structure: Viewbix Inc. entered a non-binding term sheet to acquire 100% of Quantum X Labs Ltd. (Quantum). The consideration is 65.0% of Viewbix's post-closing issued and outstanding capital stock, comprised of 19.99% in Common Stock ("Exchange Shares") and the balance in pre-funded warrants ("Exchange Pre-Funded Warrants").
- Private Placement Offering: Viewbix agreed to sell 800,000 shares of Common Stock or pre-funded warrants to accredited investors.
- Pricing: The combined purchase price is $3.75 per Private Placement Share (plus warrant) and $3.7499 per Pre-Funded Warrant (plus warrant).
- Expected Proceeds: Aggregate gross proceeds are expected to be approximately $3.0 million. Full cash exercise of warrants could yield an additional $4.5 million.
- Debt Repayment: The company plans to repay an outstanding loan of approximately $529,510 (principal and accrued interest) to L.I.A. Pure Capital Ltd. upon closing.
- Advisory Fees: A cash fee of $150,000 and a warrant to purchase 40,000 shares are payable to the advisor upon closing.
- Warrant Terms: Common Warrants have an exercise price of $5.625 and expire in five years. Pre-Funded Warrants are immediately exercisable at $0.0001.
Material Changes and Strategic Shifts
The filing represents a significant strategic pivot for Viewbix Inc. from its current operations to the quantum computing and AI sector via the acquisition of Quantum X Labs Ltd. The transaction involves a substantial dilution of existing shareholders, as the Quantum shareholders will receive 65.0% of the post-closing equity. The filing does not provide historical revenue, profit, or cash flow metrics for the current period, as it is a transactional report rather than a periodic financial statement.
Guidance, Risks, and Contingencies
- Closing Conditions: The acquisition and private placement are subject to final due diligence, execution of definitive agreements, regulatory approvals, and stockholder approval.
- Timeline: The private placement is expected to close in December 2025, contingent on the conditions above.
- Registration Rights: Viewbix must file a resale registration statement within 30 days of closing and have it declared effective within 60 to 90 days, subject to SEC review.
- Ownership Limits: Warrant holders cannot exercise if it would result in beneficial ownership exceeding 4.99% of outstanding shares.
- Forward-Looking Statements: The company explicitly warns that the closing dates and transaction completion are not guaranteed and depend on various contingencies.
Investor Verification Checklist
- Verify the final terms of the definitive acquisition agreement, as the current term sheet is non-binding.
- Confirm the outcome of the required stockholder vote for the acquisition.
- Monitor the filing and effectiveness of the resale registration statement for the private placement securities.
- Assess the financial health and technology validation of Quantum X Labs Ltd. through the upcoming due diligence process.
- Review the final capitalization table to understand the exact dilution impact on existing shareholders post-closing.